BioStem Technologies is at the forefront of advanced wound care, leveraging cutting-edge innovations derived from amniotic tissue. Our robust patent portfolio reflects our deep commitment to research and development, underscoring our drive to expand innovations in wound care through pioneering discoveries and next-generation products.

Many of these patents form the foundation of our proprietary amniotic tissue-based technologies, which are currently available in the market. Additionally, several patents represent future development opportunities within our long-term product pipeline, ensuring that we continue to lead the way in innovative wound care solutions.